Vascular endothelial growth factor-expressing neural stem cell for the treatment of neuropathic pain

Hye Lan Lee, Jinsoo Oh, Yeomin Yun, Hye Yeong Lee, Youngsang You, Lihua Che, Minhyung Lee, Keung Nyun Kim, Yoon Ha

Research output: Contribution to journalArticle

8 Citations (Scopus)

Abstract

Previously, we determined that vascular endothelial growth factor (VEGF) improves the survival of neural stem cells (NSCs) transplanted into an ischemic environment and effectively enhances angiogenesis. Here, we applied NSCs expressing VEGF (SV-VEGF-NSCs) to treat neuropathic pain. In this study, our goal was to verify the therapeutic effect of SV-VEGF-NSCs by transplanting the cells in a sciatic nerve injury model. We compared the amount of VEGF secreted from DsRed-NSCs (control) or SV-VEGFNSCs and observed that SV-VEGF-NSCs have a much higher expression level of VEGF. We next investigated whether transplantation with SV-VEGF-NSCs aids functional recovery and pain reduction. We confirmed that transplantation with SV-VEGF-NSCs enhances functional recovery, pain reduction, and remyelination as well as the number of blood vessels compared with the control groups. Our results show that VEGF aids functional recovery and pain reduction in a sciatic nerve injury model.

Original languageEnglish
Pages (from-to)399-404
Number of pages6
JournalNeuroReport
Volume26
Issue number7
DOIs
Publication statusPublished - 2015 Apr 22

Fingerprint

Neural Stem Cells
Neuralgia
Vascular Endothelial Growth Factor A
Therapeutics
Sciatic Nerve
Pain
Transplantation
Wounds and Injuries
Therapeutic Uses
Blood Vessels
Control Groups

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)

Cite this

Lee, Hye Lan ; Oh, Jinsoo ; Yun, Yeomin ; Lee, Hye Yeong ; You, Youngsang ; Che, Lihua ; Lee, Minhyung ; Kim, Keung Nyun ; Ha, Yoon. / Vascular endothelial growth factor-expressing neural stem cell for the treatment of neuropathic pain. In: NeuroReport. 2015 ; Vol. 26, No. 7. pp. 399-404.
@article{8692fccd6ebb4a6184d680ec9e9d25ce,
title = "Vascular endothelial growth factor-expressing neural stem cell for the treatment of neuropathic pain",
abstract = "Previously, we determined that vascular endothelial growth factor (VEGF) improves the survival of neural stem cells (NSCs) transplanted into an ischemic environment and effectively enhances angiogenesis. Here, we applied NSCs expressing VEGF (SV-VEGF-NSCs) to treat neuropathic pain. In this study, our goal was to verify the therapeutic effect of SV-VEGF-NSCs by transplanting the cells in a sciatic nerve injury model. We compared the amount of VEGF secreted from DsRed-NSCs (control) or SV-VEGFNSCs and observed that SV-VEGF-NSCs have a much higher expression level of VEGF. We next investigated whether transplantation with SV-VEGF-NSCs aids functional recovery and pain reduction. We confirmed that transplantation with SV-VEGF-NSCs enhances functional recovery, pain reduction, and remyelination as well as the number of blood vessels compared with the control groups. Our results show that VEGF aids functional recovery and pain reduction in a sciatic nerve injury model.",
author = "Lee, {Hye Lan} and Jinsoo Oh and Yeomin Yun and Lee, {Hye Yeong} and Youngsang You and Lihua Che and Minhyung Lee and Kim, {Keung Nyun} and Yoon Ha",
year = "2015",
month = "4",
day = "22",
doi = "10.1097/WNR.0000000000000359",
language = "English",
volume = "26",
pages = "399--404",
journal = "NeuroReport",
issn = "0959-4965",
publisher = "Lippincott Williams and Wilkins",
number = "7",

}

Vascular endothelial growth factor-expressing neural stem cell for the treatment of neuropathic pain. / Lee, Hye Lan; Oh, Jinsoo; Yun, Yeomin; Lee, Hye Yeong; You, Youngsang; Che, Lihua; Lee, Minhyung; Kim, Keung Nyun; Ha, Yoon.

In: NeuroReport, Vol. 26, No. 7, 22.04.2015, p. 399-404.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Vascular endothelial growth factor-expressing neural stem cell for the treatment of neuropathic pain

AU - Lee, Hye Lan

AU - Oh, Jinsoo

AU - Yun, Yeomin

AU - Lee, Hye Yeong

AU - You, Youngsang

AU - Che, Lihua

AU - Lee, Minhyung

AU - Kim, Keung Nyun

AU - Ha, Yoon

PY - 2015/4/22

Y1 - 2015/4/22

N2 - Previously, we determined that vascular endothelial growth factor (VEGF) improves the survival of neural stem cells (NSCs) transplanted into an ischemic environment and effectively enhances angiogenesis. Here, we applied NSCs expressing VEGF (SV-VEGF-NSCs) to treat neuropathic pain. In this study, our goal was to verify the therapeutic effect of SV-VEGF-NSCs by transplanting the cells in a sciatic nerve injury model. We compared the amount of VEGF secreted from DsRed-NSCs (control) or SV-VEGFNSCs and observed that SV-VEGF-NSCs have a much higher expression level of VEGF. We next investigated whether transplantation with SV-VEGF-NSCs aids functional recovery and pain reduction. We confirmed that transplantation with SV-VEGF-NSCs enhances functional recovery, pain reduction, and remyelination as well as the number of blood vessels compared with the control groups. Our results show that VEGF aids functional recovery and pain reduction in a sciatic nerve injury model.

AB - Previously, we determined that vascular endothelial growth factor (VEGF) improves the survival of neural stem cells (NSCs) transplanted into an ischemic environment and effectively enhances angiogenesis. Here, we applied NSCs expressing VEGF (SV-VEGF-NSCs) to treat neuropathic pain. In this study, our goal was to verify the therapeutic effect of SV-VEGF-NSCs by transplanting the cells in a sciatic nerve injury model. We compared the amount of VEGF secreted from DsRed-NSCs (control) or SV-VEGFNSCs and observed that SV-VEGF-NSCs have a much higher expression level of VEGF. We next investigated whether transplantation with SV-VEGF-NSCs aids functional recovery and pain reduction. We confirmed that transplantation with SV-VEGF-NSCs enhances functional recovery, pain reduction, and remyelination as well as the number of blood vessels compared with the control groups. Our results show that VEGF aids functional recovery and pain reduction in a sciatic nerve injury model.

UR - http://www.scopus.com/inward/record.url?scp=84928336338&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84928336338&partnerID=8YFLogxK

U2 - 10.1097/WNR.0000000000000359

DO - 10.1097/WNR.0000000000000359

M3 - Article

C2 - 25793634

AN - SCOPUS:84928336338

VL - 26

SP - 399

EP - 404

JO - NeuroReport

JF - NeuroReport

SN - 0959-4965

IS - 7

ER -